Novel artificial eye service evaluation using patient reported outcome measures.


Journal

Eye (London, England)
ISSN: 1476-5454
Titre abrégé: Eye (Lond)
Pays: England
ID NLM: 8703986

Informations de publication

Date de publication:
Jul 2021
Historique:
received: 28 06 2020
accepted: 29 09 2020
revised: 26 09 2020
pubmed: 15 10 2020
medline: 10 7 2021
entrez: 14 10 2020
Statut: ppublish

Résumé

This service evaluation explores patient reported outcomes from patients provided with high definition ocular prostheses (artificial eyes). Validated patient questionnaires (FACE-Q, DAS24 and HADS) were utilised to evaluate patient experiences of their new ocular prosthesis. 10 patients were included in the service evaluation, which was conducted between December 2018 and September 2019. Descriptive analysis of the mean and 95% CI was undertaken for all questionnaires. Statistical analysis was performed using SPSS 21 Principal Component Analysis (PCA) for FACE-Q questionnaires. Correlations were significant when factor loading is at α > 0.4. A questionnaire response rate of 80% was achieved (n = 8). PCA analysis showed the number of variables tested could be reduced. Two principal components (PC1 and PC2) had very good to excellent internal consistency between variables with factor loading (α = 0.7-0.9). PC1 contained questionnaires 1-7, all of which were highly correlated. PC2 contained question number 8 with a factor loading of α = 0.8. This indicates good reliability, validity and responsiveness. We hope to demonstrate the importance of service evaluations with respect to rapidly evolving technological advances in medical devices, pharmaceuticals and imaging modalities. Further feasibility and full clinical studies are required to confirm the positive results of the novel artificial eye service we have evaluated with respect to the traditional approach.

Sections du résumé

BACKGROUND BACKGROUND
This service evaluation explores patient reported outcomes from patients provided with high definition ocular prostheses (artificial eyes).
METHODS METHODS
Validated patient questionnaires (FACE-Q, DAS24 and HADS) were utilised to evaluate patient experiences of their new ocular prosthesis. 10 patients were included in the service evaluation, which was conducted between December 2018 and September 2019. Descriptive analysis of the mean and 95% CI was undertaken for all questionnaires. Statistical analysis was performed using SPSS 21 Principal Component Analysis (PCA) for FACE-Q questionnaires. Correlations were significant when factor loading is at α > 0.4.
RESULTS RESULTS
A questionnaire response rate of 80% was achieved (n = 8). PCA analysis showed the number of variables tested could be reduced. Two principal components (PC1 and PC2) had very good to excellent internal consistency between variables with factor loading (α = 0.7-0.9). PC1 contained questionnaires 1-7, all of which were highly correlated. PC2 contained question number 8 with a factor loading of α = 0.8. This indicates good reliability, validity and responsiveness.
CONCLUSIONS CONCLUSIONS
We hope to demonstrate the importance of service evaluations with respect to rapidly evolving technological advances in medical devices, pharmaceuticals and imaging modalities. Further feasibility and full clinical studies are required to confirm the positive results of the novel artificial eye service we have evaluated with respect to the traditional approach.

Identifiants

pubmed: 33051621
doi: 10.1038/s41433-020-01216-z
pii: 10.1038/s41433-020-01216-z
pmc: PMC8225665
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2030-2037

Références

NHS Expenditure by Rachael Harker. Documents NHS expenditure since 1948; summary of the structure of the NHS and how it is financed. https://commonslibrary.parliament.uk/research-briefings/sn00724/#:~:text=Expenditure%20on%20the%20NHS%20has,established%20on%205th%20July%201948.&text=The%20average%20annual%20expenditure%20increase,the%20history%20of%20the%20NHS . Accessed 10th Aug. 2020.
Weszl M, Rencz F, Brodszky V. Is the trend of increasing use of patient-reported outcome measures in medical device studies the sign of shift towards value-based purchasing in Europe? Eur J Health Econ. 2019;20 Suppl 1:133–40.
doi: 10.1007/s10198-019-01070-1
U.S. Food and Drug Administration: Value and use of patientreported outcomes (PROs) in assessing efects of medical devices. CDRH strategic priorities 2016–2017. https://www.fda.gov/files/about%20fda/published/Value-and-Use-of-Patient-Reported-Outcomes-%28PROs%29-in-Assessing-Effects-of-Medical-Devices.pdf Accessed 10th Aug. 2020.
Lubkin V, Sloan S. Enucleation and psychic trauma. Adv Ophthalmic Plast Reconstr Surg. 1990;8:259Y62.
McBain HB, Ezra DG, Rose GD, Newman SP. The Psychosocial impact of living with an ocular prosthesis. Orbit. 2014;33:39–44.
doi: 10.3109/01676830.2013.851251
Song JS, Oh J, Baek SH. A survey of satisfaction in an ophthalmic patients wearing ocular prosthesis. Graefes Arch Clin Exp Ophthalmol. 2006;244:330–5.
doi: 10.1007/s00417-005-0037-0
Walshaw E, Zoltie T, Bartlett P, Gout T. Manufacture of a high definition ocular prosthesis. Br J Oral Maxillofacial Surg. 2018;56:893–4.
doi: 10.1016/j.bjoms.2018.08.016
Carr T, Moss T, Harris D. The DAS24: a short form of the Derriford Appearance Scale (DAS59) to measure individual responses to living with problems of appearance. Br J Health Psych. 2005;10:285–98.
doi: 10.1348/135910705X27613
Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67:361–70.
doi: 10.1111/j.1600-0447.1983.tb09716.x
Cano SJ, Klassen A, Pusic AL. The science behind quality-of life measurement: a primer for plastic surgeons. Plast Reconstr Surg. 2009;123:98e–106e.
doi: 10.1097/PRS.0b013e31819565c1
Kosowski TR, McCarthy C, Reavey PL, Scott AM, Wilkins EG, Cano SJ, et al. A systematic review of patient-reported outcome measures after facial cosmetic surgery and/or nonsurgical facial rejuvenation. Plast Reconstr Surg. 2009;123:1819–27.
doi: 10.1097/PRS.0b013e3181a3f361
Klassen AF, Cano SJ and Pusic AL. A PROM for cosmetic facial procedures: developing the conceptual framework. International Society for Quality of Life Research meeting abstracts. QLR J, 2009:A-68, Abstract 1614.
Klassen A, Cano SJ, Scott A, Snell L, Pusic AL. Measuring patient-reported outcomes in facial aesthetic patients: development of the FACE-Q. Facial Plast Surg. 2010;26:303–9.
doi: 10.1055/s-0030-1262313
Scientific Advisory Committee of the Medical Outcomes Trust. Assessing health status and quality-of-life instruments: attributes and review criteria. Qual Life Res. 2002;11:193–205.
doi: 10.1023/A:1015291021312
Klassen AF, Cano SJ, Grotting JC, Baker SB, Carruthers J, Carruthers A, et al. FACE-Q eye module for measuring patient-reported outcomes following cosmetic eye treatments. JAMA Facial Plast Surg. 2017;19:7–14.
doi: 10.1001/jamafacial.2016.1018
Aggarwal H, Kumar P, Singh SV. Modified technique to improve fabrication and outcome of definitive orbital prosthesis. Orbit. 2016;35:66–8. Epub 2016 Feb 18.
doi: 10.3109/01676830.2015.1078379
Murthy R, Umesh M. Fabricating a custom made ocular prosthesis. Indian J Ophthalmol. 2015;63:807–8.
doi: 10.4103/0301-4738.171536
Patton MQ. Utilization-focused evaluation. Beverly Hills, CA: Sage Publishers; 1978.

Auteurs

Taras Gout (T)

Ophthalmology Trainee, Department of Ophthalmology, Leeds Teaching Hospitals NHS Trust, Leeds, UK. tarasgout@gmail.com.

Emma Grace Walshaw (EG)

Middle Grade Oral and Maxillofacial Surgery, Department of Maxillofacial Surgery, Leeds Teaching Hospitals NHS Trust, Leeds, UK.

Timothy Zoltie (T)

Head of Medical and Dental Illustration, Department of Medical and Dental Illustration, University of Leeds, Leeds, UK.

Paul Bartlett (P)

Chief Maxillofacial Prosthetist, Maxillofacial Laboratory, Leeds Teaching Hospitals NHS Trust, Leeds, UK.

Tom Archer (T)

Medical and Dental Illustrationist, Department of Medical and Dental Illustration, Leeds Teaching Hospitals NHS Trust, Leeds, UK.

Asmaa Altaie (A)

Clinical Lecturer/Honorary Speciality Registrar in Restorative Dentistry, School of Dentistry, University of Leeds, Leeds, UK.

Jiten Parmar (J)

Consultant in Oral and Maxillofacial Surgery, Department of Maxillofacial Surgery, Leeds Teaching Hospitals NHS Trust, Leeds, UK.

Nabil El-Hindy (N)

Consultant in Oculoplastics, Department of Ophthalmology, Leeds Teaching Hospitals NHS Trust, Leeds, UK.

Bernie Chang (B)

Consultant in Oculoplastics, Department of Ophthalmology, Leeds Teaching Hospitals NHS Trust, Leeds, UK.

George Kalantzis (G)

Consultant in Oculoplastics, Department of Ophthalmology, Leeds Teaching Hospitals NHS Trust, Leeds, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH